Patents by Inventor Emer Leahy
Emer Leahy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210300942Abstract: Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein Ring B, A1, A2, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.Type: ApplicationFiled: February 19, 2021Publication date: September 30, 2021Applicants: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLCInventors: Milan CHYTIL, Sharon ENGEL, Taleen G. HANANIA, Vadim ALEXANDROV, Emer LEAHY
-
Publication number: 20200024286Abstract: Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein Ring B, A1, A2, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.Type: ApplicationFiled: May 6, 2019Publication date: January 23, 2020Applicants: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLCInventors: Milan CHYTIL, Sharon ENGEL, Taleen G. HANANIA, Vadim ALEXANDROV, Emer LEAHY
-
Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease Treatments
Publication number: 20180250295Abstract: This invention provides methods of treating motor disorder side effects associated with the administration of levodopa to a subject having Parkinson's disease, by administering a dose of eltoprazine or a pharmaceutically acceptable acid addition salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with Parkinson's disease treatments, and effective doses of eltoprazine or a pharmaceutically acceptable acid addition salt thereof.Type: ApplicationFiled: May 4, 2018Publication date: September 6, 2018Inventors: Emer Leahy, Bavani Shankar -
Publication number: 20180228799Abstract: Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.Type: ApplicationFiled: April 12, 2018Publication date: August 16, 2018Inventors: Emer Leahy, Mark Day
-
Publication number: 20180057506Abstract: Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein Ring B, A1, A2, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.Type: ApplicationFiled: August 2, 2017Publication date: March 1, 2018Applicants: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLCInventors: Milan CHYTIL, Sharon Engel, Taleen G. HANANIA, Vadim ALEXANDROV, Emer LEAHY
-
Patent number: 9758529Abstract: Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein Ring B, A1, A2, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.Type: GrantFiled: February 11, 2016Date of Patent: September 12, 2017Assignees: Sunovion Pharmaceuticals Inc., PGI Drug Discovery LLCInventors: Milan Chytil, Sharon Engel, Taleen G. Hanania, Vadim Alexandrov, Emer Leahy
-
Publication number: 20160264597Abstract: Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein Ring B, A1, A2, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.Type: ApplicationFiled: February 11, 2016Publication date: September 15, 2016Inventors: Milan Chytil, Sharon Engel, Taleen G. Hanania, Vadim Alexandrov, Emer Leahy
-
Publication number: 20160067244Abstract: Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.Type: ApplicationFiled: November 18, 2015Publication date: March 10, 2016Inventors: Emer Leahy, Mark Day
-
Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease Treatments
Publication number: 20130331399Abstract: This invention provides methods of treating motor disorder side effects associated with the administration of levodopa to a subject having Parkinson's disease, by administering a dose of eltoprazine or a pharmaceutically acceptable acid addition salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with Parkinson's disease treatments, and effective doses of eltoprazine or a pharmaceutically acceptable acid addition salt thereof.Type: ApplicationFiled: June 6, 2013Publication date: December 12, 2013Inventors: Emer Leahy, Bavani Shankar -
Patent number: 8260677Abstract: A system and method for regulating a proposed transaction between a first party and a seller is provided. The method includes providing a transaction intermediary machine (TIM) on a network that is associated with a transactional limitations database storing in relation to each of a plurality of unique identifiers at least one criterion that has been established by a second party, and concerning one or more transactional limitations imposed by the second party on the first party. A request for approval (RFA) is received from the seller at the TIM having a unique identifier provided by the first party and details concerning the proposed transaction between the first party and the seller. Then, the RFA is compared with the criteria, completion of the proposed transaction is approved and a payment to the seller is also approved, and personal identification information is provided from the TIM to the seller.Type: GrantFiled: September 26, 2011Date of Patent: September 4, 2012Assignee: Totalekidz LLCInventors: Emer Leahy, Donald Perun
-
Publication number: 20120071495Abstract: Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.Type: ApplicationFiled: November 23, 2011Publication date: March 22, 2012Applicant: Psychogenics, Inc.Inventors: Emer Leahy, Mark Day
-
Publication number: 20110053956Abstract: Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.Type: ApplicationFiled: November 9, 2010Publication date: March 3, 2011Applicant: Psychogenics, Inc.Inventors: Emer Leahy, Mark Day
-
Patent number: 7882135Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subject's behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is the module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.Type: GrantFiled: July 31, 2009Date of Patent: February 1, 2011Assignee: Psychogenics, Inc.Inventors: Daniela Brunner, Vijay Gondhalekar, Emer Leahy, David LaRose, William P. Ross
-
Publication number: 20100106743Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subject's behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is the module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.Type: ApplicationFiled: July 31, 2009Publication date: April 29, 2010Applicants: Psychogenics, Inc., Carnegie Mellon UniveristyInventors: Daniela Brunner, Vijay Gondhalekar, Emer Leahy, David LaRose, William P. Ross
-
Publication number: 20090298850Abstract: Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.Type: ApplicationFiled: May 27, 2009Publication date: December 3, 2009Applicant: Psychogenics, Inc.Inventors: Emer Leahy, Mark Day
-
Patent number: 7580798Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subjects behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is the module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.Type: GrantFiled: April 27, 2007Date of Patent: August 25, 2009Assignees: Psychogenics, Inc., Carnegie Mellon UniversityInventors: Daniela Brunner, Vijay Gondhalekar, Emer Leahy, David LaRose, William P. Ross
-
Publication number: 20080306980Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subjects behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is the module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.Type: ApplicationFiled: April 27, 2007Publication date: December 11, 2008Inventors: Daniela Brunner, Vijay Gondhalekar, Emer Leahy, David LaRose, William P. Ross
-
Patent number: 7269516Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subject's behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is the module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.Type: GrantFiled: May 15, 2002Date of Patent: September 11, 2007Assignees: PsychoGenics, Inc., Carnegie Mellon UniversityInventors: Daniela Brunner, Vijay Gondhalekar, Emer Leahy, David LaRose, William P. Ross
-
Publication number: 20050004105Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans using a 5-HT1A receptor agonist is provided.Type: ApplicationFiled: January 29, 2004Publication date: January 6, 2005Inventors: Emer Leahy, Berend Olivier
-
Publication number: 20030100998Abstract: A system and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the test subject's behavior, neurology, biochemistry and physiology. The module is useful in observing the effects of a drug on the test animal and providing information on the drug's signature. Another advantage is module's portability that allows it to be used in standard laboratory cages. This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage. Additionally, the module's design allows for parallel data collection and interpretation from several laboratory animals undergoing different experiments. Multi-dimensional modeling of the test subject based the system's interpretation of the data allows pattern recognition of the drug signature, and predictive drug analysis.Type: ApplicationFiled: May 15, 2002Publication date: May 29, 2003Applicant: Carnegie Mellon University (Pittsburgh, PA) and PsychoGenics, Inc. (Hawthorne, NY)Inventors: Daniela Brunner , Vijay Gondhalekar , Emer Leahy , David LaRose , William P. Ross